Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Spina bifida occulta
ADR ID BADD_A04120
ADR Hierarchy
03      Congenital, familial and genetic disorders
03.10      Neurological disorders congenital
03.10.02      Central nervous system disorders congenital NEC
03.10.02.007      Spina bifida occulta
17      Nervous system disorders
17.19      Congenital and peripartum neurological conditions
17.19.01      Congenital and hereditary central nervous system disorders NEC
17.19.01.007      Spina bifida occulta
Description A common congenital midline defect of fusion of the vertebral arch without protrusion of the spinal cord or meninges. The lesion is also covered by skin. L5 and S1 are the most common vertebrae involved. The condition may be associated with an overlying area of hyperpigmented skin, a dermal sinus, or an abnormal patch of hair. The majority of individuals with this malformation are asymptomatic although there is an increased incidence of tethered cord syndrome and lumbar SPONDYLOSIS. (From Joynt, Clinical Neurology, 1992, Ch55, p34) [MeSH]
MedDRA Code 10041525
MeSH ID D016136
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Closed spina bifida | Spina bifida occulta | Spina Bifida Occulta | Spinal Bifida, Closed | Closed Spinal Bifida | Occult Spina Bifida | Spina Bifida, Occult | Dermal Sinus | Sinus, Dermal
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00497Clomiphene--
BADD_D00809Escitalopram0.000025%
BADD_D00932Fluoxetine0.000024%
BADD_D00952Folic acid0.000061%
BADD_D01136Imatinib0.000139%
BADD_D01252Leflunomide0.000539%
BADD_D01679Paroxetine0.000049%
BADD_D02010Sertraline0.000016%
The 1th Page    1    Total 1 Pages